Real-world multicenter assessment of sustained clinical outcomes after digital deep brain stimulation


Por: Gharabaghi, A, Groppa, S, Casas, E, Schnitzler, A, Muñoz-Delgado, L, Marshall, VL, Karl, J, Zhang, L, Alvarez, R, Feldman, MS, Soileau, MJ, Luo, L, Walter, BL, Wu, CY, Lei, H, Herz, DM, Nanduri, D, Salazar, CA, Luca, C and Weiss, D

Publicada: 14 ene 2026
Resumen:
Remote, internet-based deep brain stimulation programming for Parkinson's disease accelerates clinical benefits postoperatively by improving access to therapy adjustments compared to in-clinic optimization. After completion of the initial digital programming phase, we show that clinical outcomes, quality of life, and safety remain sustained over at least twelve months under routine care conditions. Embedding a randomized trial within a larger cohort study enables long-term, real-world evaluation, offering a scalable and pragmatic model for assessing complex digital interventions in routine clinical care. (NCT05269862 registered on 2022-03-08 and NCT04071847 registered on 2019-08-28).

Filiaciones:
Gharabaghi, A:
 Univ Tubingen, Univ Hosp Tubingen UKT, Inst Neuromodulat & Neurotechnol, Fac Med, Tubingen, Germany

 Ctr Digital Hlth, Tubingen, Germany

 Ctr B Intelligence Tubingen Stuttgart BITS, Tubingen, Germany

 German Ctr Mental Hlth DZPG, Tubingen, Germany

Groppa, S:
 Univ Hosp Homburg, Dept Neurol, Homburg, Germany

Casas, E:
 La Princesa Univ Hosp, Neurosurg Dept, Madrid, Spain

Schnitzler, A:
 Heinrich Heine Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany

 Heinrich Heine Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Med Fac, Dusseldorf, Germany

 Univ Hosp Dusseldorf, Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany

Muñoz-Delgado, L:
 Univ Seville, Serv Neurol & Neurofisiol Clin, Hosp Univ Virgen Rocio,Inst Biomed Sevilla IBiS, Unidad Trastornos Movimiento,CSIC, Seville, Spain

 Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain

Marshall, VL:
 Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Neurol, Glasgow City, Scotland

Karl, J:
 Rush Univ, Dept Neurol Sci, Chicago, IL USA

 Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

Zhang, L:
 Univ Calif Davis, Dept Neurol, Sacramento, CA USA

:
 Hosp Univ Germans Trias I Pujol, Dept Neurociencias, Serv Neurol, Unidad Enfermedades Neurodegenerat, Badalona, Spain

Feldman, MS:
 Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH USA

Soileau, MJ:
 Texas Movement Disorder Specialists PLLC, Georgetown, TX USA

Luo, L:
 Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA

Walter, BL:
 Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN USA

Wu, CY:
 Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA USA

Lei, H:
 Univ Arizona, Dept Neurol, Tucson, AZ USA

Herz, DM:
 Univ Hosp Homburg, Dept Neurol, Homburg, Germany

Nanduri, D:
 Abbott Neuromodulat, Austin, TX USA

Salazar, CA:
 Abbott Neuromodulat, Austin, TX USA

Luca, C:
 Univ Miami, Dept Neurol, Miami, FL USA

Weiss, D:
 Univ Tubingen, Ctr Neurol, Dept Neurodegenerat Dis, Tubingen, Germany

 Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany
ISSN: 23986352





npj Digital Medicine
Editorial
NATURE PORTFOLIO, HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY, Alemania
Tipo de documento: Article
Volumen: 9 Número: 1
Páginas:
WOS Id: 001682414600001
ID de PubMed: 41535352
imagen Green Submitted, gold

MÉTRICAS